Harmony Biosciences Holdings, Inc. (HRMY)
28.30
-0.24
(-0.84%)
USD |
NASDAQ |
Mar 05, 15:49
Harmony Biosciences Holdings Cash from Investing (Quarterly) : -17.63M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Castle Biosciences, Inc. | 8.831M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Amicus Therapeutics, Inc. | -6.494M |
| Iovance Biotherapeutics, Inc. | 0.775M |
| Apellis Pharmaceuticals, Inc. | -0.108M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 126.15M |
| Cash from Financing (Quarterly) | -3.015M |
| Free Cash Flow | 328.64M |
| Free Cash Flow Per Share (Quarterly) | 1.819 |
| Free Cash Flow to Equity (Quarterly) | 98.78M |
| Free Cash Flow to Firm (Quarterly) | 108.75M |
| Free Cash Flow Yield | 19.82% |